Stay updated on Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    The record describes a completed Phase 2 study of cabozantinib for advanced pancreatic neuroendocrine and carcinoid tumors. It presents the study’s eligibility criteria, treatment plan, outcomes, results, and locations.
    Difference
    53%
    Check dated 2026-11-09T13:58:23.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The footer revision label changed from v3.7.2 to v3.8.0.
    Difference
    0.2%
    Check dated 2026-11-02T16:10:26.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    A site-wide NIH banner announces a transition in terminology from “Artificial Intelligence” to “Super Intelligence” and links to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-26T15:21:12.000Z thumbnail image
  5. Check
    34 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.1 to v3.7.2 while the page continues to display a 403 error.
    Difference
    0.2%
    Check dated 2026-10-19T14:56:14.000Z thumbnail image
  6. Check
    41 days ago
    Change Detected
    Summary
    The page remains a 403 Forbidden error page; its footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T15:20:11.000Z thumbnail image
  7. Check
    62 days ago
    Change Detected
    Summary
    The study page now displays a 403 Forbidden error, blocking access to the record. This indicates an access-control issue rather than a content update.
    Difference
    19%
    Check dated 2026-09-21T22:49:27.000Z thumbnail image

Stay in the know with updates to Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib in Pancreatic Neuroendocrine & Carcinoid Tumors Clinical Trial page.